ETF warns that monoclonal antibodies may not be effective against emerging strains of SARS-CoV-2

16 décembre 2022 – The EMA’s Emergency Task Force (ETF) has cautioned that monoclonal antibodies currently authorised for COVID-19 are unlikely to be effective against emerging strains of SARS-CoV-2.

For more information, see here.